
Vzarii Therapeutics
@vzariitx
Developing innovative gene therapy platform technologies targeting mitochondrial dysfunction 🧬
ID: 1594627531109548038
http://vzariitherapeutics.com 21-11-2022 09:43:41
13 Tweet
22 Followers
11 Following

Age-related macular degeneration (AMD) is a neurodegenerative retinal disease affecting up to 10% of adults over 65 years. At BIG IDEAS – 24 November hear how Vzarii has developed innovative gene therapies that target late-stage dry AMD Enterprise Ireland #GLOBALAMBITION




Our host Anton Savage has kicked off Big Ideas 2022. Watch Live now to hear about the disruptive Irish technologies that will impact our future:rebrand.ly/BigIdeas #Bigideas2022 #GlobalAmbition Enterprise Ireland


#LoretoCallaghan from Vzarii Therapeutics Trinity Innovation KnEx spinout with their solution for late stage AMD great pitch and congratulations to Jane farrer and the whole team Enterprise Ireland Big Ideas


Age-related macular degeneration (AMD) affects up to 10% of adults over the age of 65. Vzarii Therapeutics has developed first in class innovative platform gene therapies that target late-stage dry AMD to restore mitochondrial disfunction and improve retinol function. #BigIdeas2022


Thank you to Enterprise Ireland for opportunity to pitch at BigIdeas event today Vzarii Therapeutics JaneFarrar Trinity College Dublin


Check out the latest paper from the JaneFarrar lab, detailing a novel #GeneTherapy, ophNdi1, boosting mitochondrial performance in retinal ganglion cells 🔋 TCD Genetics & Microbiology Trinity College Dublin Pharmaceutics MDPI mdpi.com/1999-4923/15/2…


6 spinouts Vzarii Therapeutics #parvalis @AilseVax from Trinity College Dublin and Probmet LEP Biomedical Renovate Pharma from RCSI presenting at Bioequity Europe next week Enterprise Ireland KTI Connect Qubis siliconrepublic.com/start-ups/iris…

Delighted that BioEquity Europe 2023 is kicking off in Trinity College Dublin this evening. Trinity Innovation KnEx. Looking forward to our spinouts pitching this week! @AilseVax Ed Lavelle , Parvalis Tx,Vzarri Therapeutics William McCormack Kingston Mills JaneFarrar Neil Gordon Paul K Qubis


Fab insights into starting and scaling biotech, won’t get better than this panel. Enterprise Ireland Irish Startups Luke O'Neill ATXA Therapeutics RemedyBio Vzarii Therapeutics @AmrytPharma APC great shout outs for colleagues in @scienceirel and IDA Ireland great chairing by Avectas Chair bio-equity


Great presentation from Loretto Callaghan on Vzarii Therapeutics - gene therapy for GA. #bioequity JaneFarrar Trinity Innovation KnEx Trinity College Dublin Enterprise Ireland TCD Genetics & Microbiology .
